Participation and survival of geriatric patients in Phase I clinical trials: The Karmanos Cancer Institute (KCI) experience

Journal of Geriatric Oncology

Volumn 2, Issue 1, 2011, Pages 18-24

  Zafar, Syed F ^a   Heilbrun, Lance K ^b   Vishnu, Prakash ^c   Jasti, Pallavi ^b   Venkatramanamoorthy, Raghu ^b   Ding, Li ^d   LoRusso, Patricia M ^b   Heath, Elisabeth I ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Barriers; Elderly; Phase I clinical trials; Survival

Indexed keywords

CYTOTOXIC AGENT;

AGED; AGING; ANEMIA; ARTICLE; CANCER CENTER; CANCER CLASSIFICATION; CANCER SURVIVAL; CLINICAL STUDY; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ELECTROLYTE DISTURBANCE; FEMALE; GERIATRIC CARE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT PARTICIPATION; PHASE 1 CLINICAL TRIAL; REFUSAL TO PARTICIPATE; SURVIVAL TIME;

EID: 78650418256     PISSN: 18794068     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgo.2010.09.004     Document Type: Article

References (17)

1. Kimmick G.G., Peterson B.L., Kornblith A.B., Mandelblatt J., Johnson J.L., Wheeler J., et al. Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001. J Clin Oncol Apr 1 2005, 23(10):2201-2207.
2. Yancik R., Ries L.A. Cancer in older persons: an international issue in an aging world. Semin Oncol Apr 2004, 31(2):128-136.
3. Townsley C.A., Selby R., Siu L.L. Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol May 1 2005, 23(13):3112-3124.
4. Basche M., Baron A.E., Eckhardt S.G., Balducci L., Persky M., Levin A., et al. Barriers to enrollment of elderly adults in early-phase cancer clinical trials. J Oncol Pract July 1 2008, 4(4):162-168.
5. Hutchins L.F., Unger J.M., Crowley J.J., Coltman C.A., Albain K.S. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med December 30 1999, 341(27):2061-2067.
6. Yee K.W.L., Pater J.L., Pho L., Zee B., Siu L.L. Enrollment of older patients in cancer treatment trials in Canada: Why is age a barrier?. J Clin Oncol April 15 2003, 21(8):1618-1623.
7. Le Tourneau C., Lee J.J., Siu L.L. Dose escalation methods in phase I cancer clinical trials. J Natl Cancer Inst May 20 2009, 101(10):708-720.
8. Aapro M.S., Kohne C.H., Cohen H.J., Extermann M. Never too old? Age should not be a barrier to enrollment in cancer clinical trials. Oncologist Mar 2005, 10(3):198-204.
9. Lee E. Statistical Methods for Survival Data Analysis 2003, Wiley & Sons Inc., New York, NY. 3rd Ed.
10. Allison P.D. Survival analysis using the SAS system: A practical guide 1995, SAS Institute, Inc., Cary, N.C.
11. Wheler J., Tsimberidou A.M., Hong D., Naing A., Jackson T., Liu S., et al. Survival of patients in a Phase 1 Clinic: the M. D. Anderson Cancer Center experience. Cancer Mar 1 2009, 115(5):1091-1099.
12. Bachelot T., Ray-Coquard I., Catimel G., Ardiet C., Guastalla J.P., Dumortier A., et al. Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials. Ann Oncol Feb 2000, 11(2):151-156.
13. Arkenau H.T., Olmos D., Ang J.E., de Bono J., Judson I., Kaye S. Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience. Br J Cancer Mar 25 2008, 98(6):1029-1033.
14. Townsley C.A., Chan K.K., Pond G.R., Marquez C., Siu L.L., Straus S.E. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials. BMC Cancer 2006, 6:34.
15. Ho J., Pond G.R., Newman C., Maclean M., Chen E.X., Oza A.M., et al. Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital. BMC Cancer 2006, 6:263.
16. Karavasilis V., Digue L., Arkenau T., Eaton D., Stapleton S., de Bono J., et al. Identification of factors limiting patient recruitment into phase I trials: a study from the Royal Marsden Hospital. Eur J Cancer May 2008, 44(7):978-982.
17. Nurgat Z.A., Craig W., Campbell N.C., Bissett J.D., Cassidy J., Nicolson M.C. Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy. Br J Cancer 2005, 92(6):1001-1005.